Teva Pharmaceutical Industries Limited (FRA:TEV)
Germany flag Germany · Delayed Price · Currency is EUR
14.20
-0.35 (-2.41%)
At close: Jul 4, 2025, 10:00 PM CET

FRA:TEV Revenue

Teva Pharmaceutical Industries had revenue of $3.89B USD in the quarter ending March 31, 2025, with 1.89% growth. This brings the company's revenue in the last twelve months to $16.62B, up 3.82% year-over-year. In the year 2024, Teva Pharmaceutical Industries had annual revenue of $16.54B with 4.40% growth.

Revenue (ttm)
$16.62B
Revenue Growth
+3.82%
P/S Ratio
1.08
Revenue / Employee
$465.62K
Employees
35,686
Market Cap
16.59B EUR

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202416.54B698.00M4.40%
Dec 31, 202315.85B921.00M6.17%
Dec 31, 202214.93B-953.00M-6.00%
Dec 31, 202115.88B-781.00M-4.69%
Dec 31, 202016.66B-228.00M-1.35%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition